期刊文献+

肿瘤转移抑制基因KiSS-1在鼻咽癌中的表达及其意义 被引量:4

The expression of KiSS-1,a metastasis suppressor gene in nasopharyngeal carcinoma and its significance
下载PDF
导出
摘要 目的:探讨KiSS-1在鼻咽癌组织中的表达及其临床意义。方法:应用逆转录聚合酶链反应(reverse transcription polymerase chain reaction,RT-PCR)检测31例鼻咽癌和14例非肿瘤性鼻咽部组织KiSS-1mRNA的表达情况,同时分析其与临床病理指标的关系。结果:KiSS-1mRNA在鼻咽癌组表达率为67.7%,非肿瘤性鼻咽部组为85.7%,两者差异无统计学意义(P>0.05),KiSS-1mRNA表达的高低与鼻咽癌患者的性别、年龄、病理类型和T分期等临床指标均无明显关系(P>0.05)。结论:KiSS-1在非肿瘤性鼻咽上皮高表达,在鼻咽癌中表达率降低。KiSS-1表达率降低与鼻咽癌的淋巴结转移有关,提示KiSS-1基因可能在鼻咽癌的转移中起重要作用。 Objective: To investigate the expression and clinical significance of KiSS-1 gene in nasopharyngeal carcinoma (NPC) tissue. Methods:KiSS-1 mRNA expression level was detected in 31 nasopharyngeal carcinoma tissues and 14 non-tumorous tissues by reverse transcription polymerase chain reaction (RT-PCR). The relationship between NPC and clinicopathological factors was also be analyzed. Results: The positive rate of KiSS-1 mRNA in nasopharyngeal carcinoma and non-tumorous nasopharyngeal tissues was 67.7% and 85.7%, respectively. The result was no significant difference between these two groups ( P 〉 0.05 ). No correlation was found between the expression of KISS-1 gene and other clinicopathological factors such as patient's sex, age, T stage (P 〉 0.05 ). Conclusions :KISS-1 gene is highly expressed in non-tumorous nasopharyngeal tissue while low expressed in NPC. Loss of KISS-1 expression was correlated with clinical stage and lymph node metastasis of NPC. These inclicated that KISS-1 may play an important role in metastasis of NPC.
出处 《蚌埠医学院学报》 CAS 2009年第7期579-581,共3页 Journal of Bengbu Medical College
基金 安徽省高校省级自然科学研究资助项目(kj2007B199)
关键词 鼻咽肿瘤 KISS-1 肿瘤转移 逆转录聚合酶链反应 nasopharyngeal neoplasms KiSS-1 neoplasm metastasis reverse transcription polymerase chain reaction
  • 相关文献

参考文献7

二级参考文献63

  • 1余巨明,王坚,任惠民,蒋雨平.小鼠癫痫持续状态后海马活化素A、抑制素A蛋白及活化素受体ⅡAmRNA表达的变化[J].中华神经医学杂志,2004,3(6):411-414. 被引量:1
  • 2谭浩,许民辉,周继红,邹咏文,张云东.严重创伤早期大鼠下丘脑G蛋白偶联受体激酶的变化[J].中华神经医学杂志,2005,4(2):130-132. 被引量:2
  • 3Bijesh Raj Ghimire,林立平,郭颖,张力.同期化放疗在局部晚期鼻咽癌治疗中的作用:一项关于Ⅲ期随机对照试验的荟萃分析[J].循证医学,2007,7(3):158-166. 被引量:18
  • 4高云生,应红梅,熊小鹏,胡超苏.局部晚期鼻咽癌放疗与化疗综合治疗的生存分析[J].中华放射肿瘤学杂志,2007,16(4):241-244. 被引量:29
  • 5Preliminary results of a randomized trial comparing neoadjuvant chemotherapy ( cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage Ⅳ(> or = N2, M0 ) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival. International Nasopharynx Cancer Study Group. VUMCA Ⅰ trial[ J]. Int J Radiat Oncol Biol Phys, 1996,35 (3) :463 -469.
  • 6Chua DT, Sham JS, Choy D, et al. Preliminary report of the Asian- Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group [ J ]. Cancer, 1998,83 ( 11 ) :2 270 - 2 283.
  • 7Kwong DL, Sham JS, Au GK, et al. Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma:a factorial study [ J ]. J Clin Oncol,2004,22( 13 ) :2 643 -2 453.
  • 8Rossi A, Molinari R, Boracchi P, et al. Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year muhicenter randomized study [ J ]. J Clin Oncol, 1988,6 ( 9 ) :1401-1 410.
  • 9Lin JC, Chen KY, Jan JS, et al. Partially hyperfractionated accelerated radiotherapy and concurrent chemotherapy for advanced nasopharyngeal carcinoma [ J ]. Int J Radiat Oncol Biol Phys,1996,36(5) :1 127 - 1 236.
  • 10孙燕 周际昌.临床肿瘤内科手册[M](第3版)[M].北京:人民卫生出版社,1996.33.

共引文献22

同被引文献39

  • 1孟薇,王一飞.nm23基因抑制肿瘤转移机制研究进展[J].国际肿瘤学杂志,2006,33(5):338-341. 被引量:5
  • 2张潜英,陈鸿雁.肿瘤转移抑制基因RECK[J].重庆医科大学学报,2007,32(3):328-330. 被引量:2
  • 3Sridhar S C, Miranti C K. Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin - dependent crosstalk with c Met receptor and Src kinases[J]. Oncogene, 2006, 25 : 2367.
  • 4Bandyopadhyay A, Agyin J K, Wang I., et al. Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-b type 1 receptor kinase inhibilor[J ]. Cancer Research, 2006, 66: 6714.
  • 5Potter J D. Morphogens, morphostats, microarchiteeture and malignancy[J]. Nature Reviews Cromer, 2007, 7: 464.
  • 6Peinado H, Olmeda D, Cano A. Snail, ZEB and bHLH factors in turnout progression: An alliance against the epithelial phenotype[J]. Nature Reviews Cancer, 2007, 7: 415.
  • 7Kallakury B V, Yang F, Figge J, et al. Decreased levels of CD44 protein and mRNA in prostate carcinoma Correlation with tumor grade and ploidy[J]. Cancer, 1996, 78: 1461.
  • 8Kaetzel D M, Zhang Q B, Yang M M, et al. Potential roles of 3- 5- exonuclease activity of NM23 -H1 in DNA repair and maligr,ant progression [J].Journal of Bioenergeties and Bionmmbranes, 2003, 8: 163.
  • 9Nash K T, Welch D R. The KISSI metastasis suppressor: Mechanistic insights and clinical utility[J ]. Frontiers in Bio science, 2006, 11 : 647.
  • 10Hickson J A, Huo D, Vander Griend D J, et al. The p38 Kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma[J].Cancer Research, 2006, 66: 2264.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部